Impact of Molecular Tumor Board (MTB) on precision oncology in a community setting

被引:0
|
作者
ElNaggar, Adam [1 ]
Vidal, Gregory [1 ]
VanderWalde, Ari [1 ]
Schwartzberg, Lee [1 ]
Grothey, Axel [1 ]
Vaena, Daniel [1 ]
Bufalino, Gabriella [1 ]
机构
[1] West Canc Ctr & Res Inst, Memphis, TN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
336
引用
收藏
页码:S180 / S180
页数:1
相关论文
共 50 条
  • [31] Precision medicine: imaging in the context of the molecular tumor board
    Gaidzik, Verena I. I.
    Beer, Ambros J. J.
    Thaiss, Wolfgang
    [J]. ONKOLOGIE, 2023, 29 (12): : 1035 - 1042
  • [32] Molecular Tumor Boards: Realizing Precision Oncology Therapy
    Patel, Maulik
    Kato, Shumei M.
    Kurzrock, Razelle
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 206 - 209
  • [33] The impact of circulating tumor DNA analyses on precision oncology
    Speicher, M. R.
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 175 - 175
  • [34] Contributing factors for diagnostic delays in advanced lung cancer (LC) patients and the role of multidisciplinary tumor board (MTB) discussion in a community hospital setting
    Sunkara, Rajitha
    Soyano, Aixa
    Rafieq, Samaan
    Martin, Leslie A.
    Lee, David
    Chi, Dorcas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Pan-tumor circulating tumor DNA testing in the community oncology setting
    Raska, Paola
    Su, Zhaohui
    Robert, Nicholas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] Implementation and utilization of the molecular tumor board to guide precision medicine
    Harada, Shuko
    Arend, Rebecca
    Dai, Qian
    Levesque, Jessica A.
    Winokur, Thomas S.
    Guo, Rongjun
    Heslin, Martin J.
    Nabell, Lisle
    Nabors, L. Burt
    Limdi, Nita A.
    Roth, Kevin A.
    Partridge, Edward E.
    Siegal, Gene P.
    Yang, Eddy S.
    [J]. ONCOTARGET, 2017, 8 (34) : 57845 - 57854
  • [37] Molecular tumor board (MTB): Development of clinical pathways for precision medicine. Experiences of center for breast cancer at national cancer center, Korea
    Park, I. H.
    Park, C.
    Jang, W.
    Yang, H.
    An, K.
    Kwon, Y.
    Lee, K. S.
    Sim, H.
    Kong, S. Y.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [38] NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board Analysis
    Gremke, Niklas
    Rodepeter, Fiona R.
    Teply-Szymanski, Julia
    Griewing, Sebastian
    Boekhoff, Jelena
    Stroh, Alina
    Tarawneh, Thomas S.
    Riera-Knorrenschild, Jorge
    Balser, Christina
    Hattesohl, Akira
    Middeke, Martin
    Ross, Petra
    Litmeyer, Anne-Sophie
    Romey, Marcel
    Stiewe, Thorsten
    Wuendisch, Thomas
    Neubauer, Andreas
    Denkert, Carsten
    Wagner, Uwe
    Mack, Elisabeth K. M.
    [J]. CANCERS, 2024, 16 (08)
  • [39] Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
    Fujiwara, Yu
    Kato, Shumei
    Kurzrock, Razelle
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (02) : 197 - 216
  • [40] Precision Oncology and Molecular Tumor Boards - Concepts, Opportunities and Challenges
    Holch, Julian Walter
    Westphalen, Benedikt
    Hiddemann, Wolfgang
    Heinemann, Volker
    Jung, Andreas
    Metzeler, Klaus
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (22) : 1676 - 1684